Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders
Open accessThe DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
SHANK3 (also known as ProSAP2) regulates the structural organization of dendritic spines and is a binding partner of neuroligins; genes encoding neuroligins are mutated in autism and Asperger syndrome. Here, we report that a mutation of a single copy of SHANK3 on chromosome 22q13 can result in language and/or social communication disorders. These mutations concern only a small number of individuals, but they shed light on one gene dosage-sensitive synaptic pathway that is involved in autism spectrum disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Loss of a functional copy of the SHANK3 gene leads to the neurobehavioral manifestations of 22q13 deletion syndrome and/or to autism spectrum disorders.”
From Haploinsufficiency of the autism-associated Shank3 gene leads to deficits in synaptic function, social interaction, and social communication (2010) · cites this paper as [26]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The variations identified included de novo deleterious mutations and inherited non-synonymous variations affecting highly conserved amino acids in the ankyrin domain.6, 7”
From SHANK3 mutations identified in autism lead to modification of dendritic spine morphology via an actin-dependent mechanism (2012) · cites this paper as [6]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The remaining three mutations are non-synonymous mutations located in or near the highly conserved ankyrin domain (R12C, R300C and Q321R, referred to as Shank3R12C, Shank3R300C and Shank3Q321R, respectively).6, 7”
From SHANK3 mutations identified in autism lead to modification of dendritic spine morphology via an actin-dependent mechanism (2012) · cites this paper as [6]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Recent human genetic studies indicate that SHANK family genes (SHANK1, SHANK2, and SHANK3) are causative genes for idiopathic autism spectrum disorders (ASD).”
From Modeling Autism by SHANK Gene Mutations in Mice (2013) · cites this paper as Durand et al., 2007
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In three families from France and Canada, the SHANK3 deletions originated from a balanced translocation present in a healthy parent [6], [13].”
From Meta-analysis of SHANK Mutations in Autism Spectrum Disorders: A Gradient of Severity in Cognitive Impairments (2014) · cites this paper as [6]
Experimental — accuracy not yet measured
21 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A forkhead-domain gene is mutated in a severe speech and language disorder
Lai, C. S. L., Fisher, S. E., Hurst, J. A., Vargha-Khadem, F., & Monaco, A. P. (2001) · Nature · doi:10.1038/35097076 · Cited by 2,054
Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism
Study, P. A. R. I. S., Jamain, S., Quach, H., Betancur, C., Råstam, M., Colineaux, C., Gillberg, I. C., Soderstrom, H., Giros, B., Leboyer, M., et al. (2003) · Nature Genetics · doi:10.1038/ng1136 · Cited by 1,851
Self-citationNaisbitt, S., Kim, E., Tu, J. C., Xiao, B., Sala, C., Valtschanoff, J., Weinberg, R. J., Worley, P. F., & Sheng, M. (1999) · Neuron · doi:10.1016/s0896-6273(00)80809-0 · Cited by 1,009
Genetics of austim: complex aetiology for a heterogeneous disorder
Folstein, S. E., & Rosen-Sheidley, B. (2001) · Nature Reviews Genetics · doi:10.1038/35103559 · Cited by 771
Searching for ways out of the autism maze: genetic, epigenetic and environmental clues
Persico, A. M., & Bourgeron, T. (2006) · Trends in Neurosciences · doi:10.1016/j.tins.2006.05.010 · Cited by 575
Self-citationVorstman, J. A. S., Staal, W. G., van Daalen, E., van Engeland, H., Hochstenbach, P. F. R., & Franke, L. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001757 · Cited by 353
Spine architecture and synaptic plasticity
Carlisle, H. J., & Kennedy, M. B. (2005) · Trends in Neurosciences · doi:10.1016/j.tins.2005.01.008 · Cited by 350
Boeckers, T. M., Bockmann, J., Kreutz, M. R., & Gundelfinger, E. D. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00931.x · Cited by 349
Self-citationSevere Expressive-Language Delay Related to Duplication of the Williams–Beuren Locus
Somerville, M. J., Mervis, C. B., Young, E. J., Seo, E.-J., del Campo, M., Bamforth, S., Peregrine, E., Loo, W., Lilley, M., Pérez-Jurado, L. A., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051962 · Cited by 312
Bonaglia, M. C., Giorda, R., Borgatti, R., Felisari, G., Gagliardi, C., Selicorni, A., & Zuffardi, O. (2001) · The American Journal of Human Genetics · doi:10.1086/321293 · Cited by 309
Cited by
Items 401–500 of 1,004
Copping, N. A., Berg, E. L., Foley, G. M., Schaffler, M. D., Onaga, B., Buscher, N., Silverman, J. L., & Yang, M. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.05.016 · Cited by 79
“…SHANK3 due to deletion or de novo mutations occurs in approximately 1% of autism spectrum disorder (ASD) cases, making SHANK3 abnormalities one of the most common genetic causes of autism (Durand et al., 2007; Moessner et al., 2007; Buxbaum, 2009; Betancur and Buxbaum, 2013; Boccuto et al., 2013).”
BackgroundMonogenic mouse models of autism spectrum disorders: Common mechanisms and missing links
Hulbert, S. W., & Jiang, Y. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.12.040 · Cited by 86
“1 Shanks (Phelan-McDermid syndrome and non-syndromic ASDs)— Mutations in the SHANK/ProSAP family genes (SHANK1–3), particularly SHANK2 and SHANK3, have been identified recently as pathogenic for non-syndromic ASDs (Durand et al., 2007; Berkel et al., 2010; Sato et al., 2012).”
Backgroundde Bruijn, D. R. H., van Dijk, A. H. A., Pfundt, R., Hoischen, A., Merkx, G. F. M., Gradek, G. A., Lybæk, H., Stray-Pedersen, A., Brunner, H. G., & Houge, G. (2010) · Molecular Syndromology · doi:10.1159/000280290 · Cited by 75
“Mutations in 3 other PSD-associated genes can be rare causes of autism [Jamain et al., 2003; Durand et al., 2007].”
BackgroundNeurobiology of autism gene products: towards pathogenesis and drug targets
Kleijer, K. T. E., Schmeisser, M. J., Krueger, D. D., Boeckers, T. M., Scheiffele, P., Bourgeron, T., Brose, N., & Burbach, J. P. H. (2014) · Psychopharmacology · doi:10.1007/s00213-013-3403-3 · Cited by 75
“…mutation of Abelson’s Helper Intregration 1 (AHI1) (Alvarez Retuerto et al. 2008), Phelan-McDermid syndrome, involving SHANK3 as the critical gene (Durand et al. 2007; Phelan andMcDermid 2011), 3p deletion syndrome involving a microdeletion hitting three cell adhesion genes CNTN4, CHL1, and…”
BackgroundSelf-citationCarlisle, H. J., Luong, T. N., Medina-Marino, A., Schenker, L., Khorosheva, E., Indersmitten, T., Gunapala, K. M., Steele, A. D., O'Dell, T. J., Patterson, P. H., et al. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.5877-10.2011 · Cited by 74
“Associated with Mental Illness and Reduces mGluR5 and”
BackgroundInfluentialA double hit implicates DIAPH3 as an autism risk gene
Vorstman, J. A. S., van Daalen, E., Jalali, G. R., Schmidt, E. R. E., Pasterkamp, R. J., de Jonge, M., Hennekam, E. A. M., Janson, E., Staal, W. G., van der Zwaag, B., et al. (2011) · Molecular Psychiatry · doi:10.1038/mp.2010.26 · Cited by 74
“Interestingly, SHANK3, a gene that was recently reported as a novel candidate gene for ASDs”
BackgroundAutism-associated SHANK3 mutations impair maturation of neuromuscular junctions and striated muscles
Lutz, A.-K., Pfaender, S., Incearap, B., Ioannidis, V., Ottonelli, I., Föhr, K. J., Cammerer, J., Zoller, M., Higelin, J., Giona, F., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aaz3267 · Cited by 79
Self-citationTao, K., Chung, M., Watarai, A., Huang, Z., Wang, M.-Y., & Okuyama, T. (2022) · Molecular Psychiatry · doi:10.1038/s41380-021-01430-5 · Cited by 73
“SH3 and multiple ankyrin repeat domains 3 (Shank3), one of the most promising ASDsusceptibility genes [21], encodes a postsynaptic scaffolding protein [22], and ASD model mice generated by deleting Shank3 are characterized by reduced social interactions and abnormal social novelty recognition [23, 24].”
BackgroundSadakata, T., Shinoda, Y., Oka, M., Sekine, Y., Sato, Y., Saruta, C., Miwa, H., Tanaka, M., Itohara, S., & Furuichi, T. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1210055109 · Cited by 73
Dances with black widow spiders: Dysregulation of glutamate signalling enters centre stage in ADHD
Lesch, K., Merker, S., Reif, A., & Novak, M. (2012) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2012.07.013 · Cited by 80
“…autism spectrum disorders (ASD) which are characterised by impairments in social interaction and communication as well as restricted behavioural patterns and interests and which display syndromic overlap with ADHD (Durand et al., 2007; Moessner et al., 2007) for review: (Grabrucker et al., 2011).”
BackgroundNava, C., Keren, B., Mignot, C., Rastetter, A., Chantot‐Bastaraud, S., Faudet, A., Fonteneau, E., Amiet, C., Laurent‐Levinson, C., Jacquette, A., et al. (2013) · European Journal of Human Genetics · doi:10.1038/ejhg.2013.88 · Cited by 78
Self-citationAutism Spectrum Disorder Genetics: Diverse Genes with Diverse Clinical Outcomes
Talkowski, M. E., Minikel, E. V., & Gusella, J. F. (2014) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000002 · Cited by 72
Sungur, A. Ö., Schwarting, R. K. W., & Wöhr, M. (2016) · Autism Research · doi:10.1002/aur.1564 · Cited by 72
The PI3K signaling pathway as a pharmacological target in Autism related disorders and Schizophrenia
Enriquez-Barreto, L., & Morales, M. (2016) · Molecular and Cellular Therapies · doi:10.1186/s40591-016-0047-9 · Cited by 72
Aldinger, K. A., Kogan, J., Kimonis, V., Fernandez, B., Horn, D., Klopocki, E., Chung, B., Toutain, A., Weksberg, R., Millen, K. J., et al. (2013) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.35700 · Cited by 72
“SHANK3 is strongly expressed in the cerebral cortex and cerebellum and has been proposed as the major cause for both the neurological features of the 22q13 deletion syndrome and for a monogenic form of autism [Bonaglia et al., 2001; Durand et al., 2007; Moessner et al., 2007].”
BackgroundMa, K., Qin, L., Matas, E., Duffney, L. J., Liu, A., & Yan, Z. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0073-1 · Cited by 71
Association of GTF2i in the Williams-Beuren Syndrome Critical Region with Autism Spectrum Disorders
Malenfant, P., Liu, X., Hudson, M. L., Qiao, Y., Hrynchak, M. A., Riendeau, N., Hildebrand, M. J., Cohen, I. L., Chudley, A. E., Forster‐Gibson, C., et al. (2011) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-011-1389-4 · Cited by 80
Shank mutant mice as an animal model of autism
Yoo, J., Bakes, J., Bradley, C. A., Collingridge, G. L., & Kaang, B. (2014) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2013.0143 · Cited by 80
Optimizing neuronal differentiation from induced pluripotent stem cells to model ASD
Kim, D.-S., Ross, P. J., Zaslavsky, K., & Ellis, J. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00109 · Cited by 70
“REVIEW ARTICLE published: 11 April 2014 doi: 10.3389/fncel.2014.00109 Optimizing neuronal differentiation from induced pluripotent stem cells to model ASD”
BackgroundInfluentialAL-Ayadhi, L. Y., Zayed, N., Bhat, R. S., Moubayed, N., Al-Muammar, M. N., & El-Ansary, A. (2021) · Gut Pathogens · doi:10.1186/s13099-021-00448-y · Cited by 81
Sungur, A. Ö., Vörckel, K. J., Schwarting, R. K. W., & Wöhr, M. (2014) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2014.05.003 · Cited by 81
Thomas, M. S. C., Knowland, V. C. P., & Karmiloff-Smith, A. (2011) · Psychological Review · doi:10.1037/a0025234 · Cited by 70
Yin, C., Chen, H.-I., Li, L., Chien, Y., Liao, H., Chou, M. C., Chou, W., Tsai, W., Chiu, Y., Wu, Y., et al. (2016) · Molecular Autism · doi:10.1186/s13229-016-0087-7 · Cited by 75
“Many of these loci/genes are relevant to the process of neurotransmission [10–12], synapse formation [10, 11], or protein ubiquitination [12].”
BackgroundInternational Molecular Genetic Study of Autism Consortium (IMGSAC), Sykes, N. H., Toma, C., Wilson, N., Volpi, E. V., Sousa, I., Pagnamenta, A. T., Tancredi, R., Battaglia, A., Maestrini, E., et al. (2009) · European Journal of Human Genetics · doi:10.1038/ejhg.2009.47 · Cited by 69
“Sequence analysis was not conducted and so rare mutations potentially could have been missed within SHANK3 such as those found in previous studies 21,26,27.”
Poot, M., van der Smagt, J. J., Brilstra, E. H., & Bourgeron, T. (2011) · Cytogenetic and Genome Research · doi:10.1159/000334064 · Cited by 69
“Consequently, in few patients fully penetrant mutations in genes or CNVs have been identified [Jamain et al., 2003; Reddy, 2005; Durand et al., 2007; van der Zwaag et al., 2010].”
BackgroundSelf-citationLevy, T., Foss‐Feig, J. H., Betancur, C., Siper, P. M., Trelles, M. D. P., Halpern, D. B., Frank, Y., Lozano, R., Layton, C., Britvan, B., et al. (2021) · Human Molecular Genetics · doi:10.1093/hmg/ddab280 · Cited by 75
Self-citationWhole Genome Scanning: Resolving Clinical Diagnosis and Management Amidst Complex Data
Ali‐Khan, S. E., Daar, A. S., Shuman, C. T., Ray, P. N., & Scherer, S. W. (2009) · Pediatric Research · doi:10.1203/pdr.0b013e3181b0cbd8 · Cited by 72
Qiu, S., Lu, Z., & Levitt, P. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.2580-14.2014 · Cited by 69
“Disruption of the molecular components that impact excitatory synapse structure and function are evident with deleterious, rare mutations of adhesion, adaptor, and signaling synaptic proteins (Durand et al., 2007; Tabuchi et al., 2007; Gilman et al., 2011; Hamdan et al., 2011).”
BackgroundChoi, S.-Y., Pang, K., Kim, J. Y., Ryu, J. R., Kang, H., Liu, Z., Kim, W.-K., Sun, W., Kim, H., & Han, K. (2015) · Molecular Brain · doi:10.1186/s13041-015-0165-3 · Cited by 69
“Asperger syndrome, attention deficit hyperactivity disorder, schizophrenia and bipolar disorder [9–12].”
BackgroundZwanenburg, R. J., Ruiter, S., van den Heuvel, E. R., Flapper, B. C. T., & van Ravenswaaij‐Arts, C. M. A. (2016) · Journal of Neurodevelopmental Disorders · doi:10.1186/s11689-016-9150-0 · Cited by 74
“Individuals with an intragenic deletion or a mutation of SHANK3 share the features of intellectual disability and autistic behaviour [12–14], making 22q13.”
Enhancing inhibitory synaptic function reverses spatial memory deficits in Shank2 mutant mice
Lim, C., Kim, H., Yu, N., Kang, S. J., Kim, T., Ko, H., Lee, J., Yang, J.-E., Ryu, H.-H., Park, T., et al. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.08.016 · Cited by 79
“In addition, several other synaptic genes such as NLGN4, NRXN1, SHANK2, SHANK3 and CNTNAP2 had been associated with idiopathic ASDs (Alarcon et al., 2008; Berkel et al., 2010; Durand et al., 2007; Feng et al., 2006; Jamain et al., 2003).”
Self-citationMorimura, N., Yasuda, H., Yamaguchi, K., Katayama, K.-I., Hatayama, M., Tomioka, N. H., Odagawa, M., Kamiya, A., Iwayama, Y., Maekawa, M., et al. (2017) · Nature Communications · doi:10.1038/ncomms15800 · Cited by 68
“Mutations in NRXN1 , NLGN3/4 and SHANK1/2/3 alter synaptic function and lead to autism spectrum disorders (ASD), intellectual disability or schizophrenia 2,4–7 .”
Behavioral and Cerebellar Transmission Deficits in Mice Lacking the Autism-Linked Gene Islet Brain-2
Giza, J., Urbanski, M. J., Prestori, F., Bandyopadhyay, B., Yam, A., Friedrich, V., Kelley, K., D'Angelo, E., & Goldfarb, M. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.1161-10.2010 · Cited by 68
“It remains to be determined whether related functional deficits occur in IB2 / mice or in mice hemizygous for IB2 together with neighboring genes, such as SHANK3.”
BackgroundInfluentialGenome-wide association study meta-analysis of suicide death and suicidal behavior
Li, Q. S., Shabalin, A. A., DiBlasi, E., Gopal, S., Canuso, C. M., FinnGen, I. S. G. C., Palotie, A., Drevets, W. C., Docherty, A. R., & Coon, H. (2023) · Molecular Psychiatry · doi:10.1038/s41380-022-01828-9 · Cited by 68
Schizophrenia Related Variants in CACNA1C also Confer Risk of Autism
Li, J., Zhao, L., You, Y., Lu, T., Jia, M., Yu, H., Ruan, Y., Yue, W., Liu, J., Lu, L., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0133247 · Cited by 68
“The susceptibility genes (such as DISC1 [33,34], RELN [35,36], GABA [37–39], SHANK3 [40,41], NRXN1 [20,42], NTNG1 [43,44], etc.), which were associated with schizophrenia, also confer risk to ASD.”
The role of Pax6 in brain development and its impact on pathogenesis of autism spectrum disorder
Kikkawa, T., Casingal, C. R., Chun, S. H., Shinohara, H. M., Hiraoka, K., & Osumi, N. (2018) · Brain Research · doi:10.1016/j.brainres.2018.02.041 · Cited by 77
Shank3-Rich2 Interaction Regulates AMPA Receptor Recycling and Synaptic Long-Term Potentiation
Raynaud, F., Janossy, A., Dahl, J., Bertaso, F., Perroy, J., Varrault, A., Vidal, M., Worley, P. F., Boeckers, T. M., Bockaert, J., et al. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.2725-12.2013 · Cited by 68
“Mutations/deletions of Shank3 have been associated with the 22q13 deletion mental retardation syndrome and autism, thus designating Shank3 as a putative biological substrate for these pathologies (Bonaglia et al., 2006; Durand et al., 2007, 2012).”
BackgroundSelf-citationRaymond, L. J., Deth, R. C., & Ralston, N. V. C. (2014) · Autism Research and Treatment · doi:10.1155/2014/164938 · Cited by 81
“Observations from family studies suggest that ASD has a strong genetic component [103–105], although the failure to identify genetic factors affecting more than a small proportion of ASD cases suggests that multiple etiologies may be responsible for the pathologies and neurobehavioral features of the disorder [106–117…”
BackgroundSynaptic Signaling and Aberrant RNA Splicing in Autism Spectrum Disorders
Smith, R. M., & Sadée, W. (2011) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2011.00001 · Cited by 74
“…within CAM and scaffold genes have revealed few disease-causing coding variants shared among affected individuals (Vincent et al., 2004; Gauthier et al., 2005, 2009; Yan et al., 2005, 2008; Ylisaukko-oja et al., 2005; Blasi et al., 2006; Feng et al., 2006; Durand et al., 2007; Berkel et al., 2010).”
MicroRNAs: Not “Fine-Tuners” but Key Regulators of Neuronal Development and Function
Davis, G. M., Haas, M. A., & Pocock, R. (2015) · Frontiers in Neurology · doi:10.3389/fneur.2015.00245 · Cited by 67
“This included miRNAs that are predicted to target the synaptic scaffolding protein, SHANK3, and the presynaptic cell adhesion protein, NRXN1, which are both associated with ASDs (163, 164).”
BackgroundPfaender, S., Sauer, A. K., Hagmeyer, S., Mangus, K., Linta, L., Liebau, S., Bockmann, J., Huguet, G., Bourgeron, T., Boeckers, T. M., et al. (2017) · Scientific Reports · doi:10.1038/srep45190 · Cited by 76
Self-citationDeficiency of Shank2 causes mania-like behavior that responds to mood stabilizers
Pappas, A. L., Bey, A. L., Wang, X., Rossi, M., Kim, Y. H., Yan, H., Porkka, F., Duffney, L. J., Phillips, S. M., Cao, X., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.92052 · Cited by 67
Verma, V., Paul, A., Vishwanath, A. A., Vaidya, B., & Clement, J. P. (2019) · Open Biology · doi:10.1098/rsob.180265 · Cited by 71
Shank and Zinc Mediate an AMPA Receptor Subunit Switch in Developing Neurons
Ha, H., Leal‐Ortiz, S., Lalwani, K., Kiyonaka, S., Hamachi, I., Mysore, S. P., Montgomery, J. M., Garner, C. C., Huguenard, J. R., & Kim, S. A. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00405 · Cited by 76
“, 2008), and the Shank family of proteins (Durand et al., 2007; Berkel et al., 2010; Leblond et al., 2012; Sato et al., 2012).”
BackgroundRistori, M. V., Mortera, S. L., Marzano, V., Guerrera, S., Vernocchi, P., Ianiro, G., Gardini, S., Torre, G., Valeri, G., Vicari, S., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176274 · Cited by 75
“In particular, gene inheritance has been found in around 60% [11,12] or 80% [13] of cases with significant heterogeneity concerning the genetic factors actually involved in ASD onset [14,15].”
BackgroundThe PHF21B gene is associated with major depression and modulates the stress response
Wong, M., Arcos‐Burgos, M., Liu, S., Velez, J. I., Yu, C., Baune, B. T., Jawahar, M. C., Arolt, V., Dannlowski, U., Chuah, A., et al. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.174 · Cited by 66
“62,63 It is noteworthy that the nearby 22q11.”
Gouder, L., Vitrac, A., Goubran-Botros, H., Danckaert, A., Tinevez, J.-Y., André-Leroux, G., Atanasova, E., Lemière, N., Biton, A., Leblond, C. S., et al. (2019) · Scientific Reports · doi:10.1038/s41598-018-36993-x · Cited by 65
Self-citationKunde, S., Rademacher, N., Tzschach, A., Wiedersberg, E., Ullmann, R., Kalscheuer, V. M., & Shoichet, S. A. (2013) · Human Genetics · doi:10.1007/s00439-012-1260-5 · Cited by 66
Lateral organization of the postsynaptic density
MacGillavry, H. D., Kerr, J. M., & Blanpied, T. A. (2011) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2011.09.001 · Cited by 66
“In the case of the PSD, Shank3 genetic mutations and deletions are linked to autism spectrum and other neurodevelopmental disorders (Bonaglia et al., 2001; Durand et al., 2007) as well as schizophrenia (Gauthier et al., 2010).”
BackgroundCo-expression Profiling of Autism Genes in the Mouse Brain
Menashe, I., Grange, P., Larsen, E. C., Banerjee-Basu, S., & Mitra, P. P. (2013) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1003128 · Cited by 67
“In this realm, genes involved in synapse formation and brain circuitry are consistently found to be dysregulated in people with ASD [12–14].”
BackgroundTordjman, S., Cohen, D., Anderson, G. M., Botbol, M., Canitano, R., Coulon, N., & Roubertoux, P. L. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.01.014 · Cited by 76
Eps8 controls dendritic spine density and synaptic plasticity through its actin‐capping activity
Menna, E., Zambetti, S., Morini, R., Donzelli, A., Disanza, A., Calvigioni, D., Braida, D., Nicolini, C., Orlando, M., Fossati, G., et al. (2013) · The EMBO Journal · doi:10.1038/emboj.2013.107 · Cited by 76
“…and Bear, 2008; Bourgeron, 2009) involved in regulation of spine protein synthesis, the Neurexin–Neuroligin–Shank pathway (Jamain et al , 2003; Durand et al , 2007) associated with synaptogenesis and excitation-inhibition imbalance, and Ras/ Rho GTPase pathway (Pinto et al , 2010)…”
Bramswig, N. C., Lüdecke, H.-J., Alanay, Y., Albrecht, B., Barthelmie, A., Boduroglu, K., Braunholz, D., Caliebe, A., Chrzanowska, K. H., Czeschik, J. C., et al. (2015) · Human Genetics · doi:10.1007/s00439-015-1535-8 · Cited by 65
Daimon, C. M., Jasien, J. M., Wood, W. H., Zhang, Y., Becker, K. G., Silverman, J. L., Crawley, J. N., Martin, B., & Maudsley, S. (2015) · Frontiers in Physiology · doi:10.3389/fphys.2015.00324 · Cited by 66
“Overall, Technische Universität Dresden, Germany *Correspondence: Stuart Maudsley stuart.maudsley@molgen.vib-ua.be Specialty section: This article was submitted to Integrative Physiology, a section of the journal Frontiers in Physiology Received: 15 July 2015 Accepted: 27 October 2015 Published: 24 November 2015 Citat…”
BackgroundMethodInfluentialLucariello, M., Vidal, E., Vidal, S., Sáez, M., Roa, L., Huertas, D., Pineda, M., Dalfó, E., Dopazo, J., Jurado, P., et al. (2016) · Human Genetics · doi:10.1007/s00439-016-1721-3 · Cited by 74
Dendritic spine actin cytoskeleton in autism spectrum disorder
Joensuu, M., Lanoue, V., & Hotulainen, P. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.08.023 · Cited by 65
Targets for Drug Therapy for Autism Spectrum Disorder: Challenges and Future Directions
Lacivita, E., Perrone, R., Margari, L., & Leopoldo, M. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00965 · Cited by 78
De novo Mutations (DNMs) in Autism Spectrum Disorder (ASD): Pathway and Network Analysis
Alonso-González, A., Rodriguez‐Fontenla, C., & Carracedo, Á. (2018) · Frontiers in Genetics · doi:10.3389/fgene.2018.00406 · Cited by 87
“, 2003), SHANK3 (Durand et al., 2006), NRXN1 (Autism Genome Project Consortium et al.”
An autism-linked missense mutation in SHANK3 reveals the modularity of Shank3 function
Wang, L., Pang, K., Han, K., Adamski, C. J., Wang, W., He, L., Lai, J. K., Bondar, V. V., Duman, J. G., Richman, R., et al. (2020) · Molecular Psychiatry · doi:10.1038/s41380-018-0324-x · Cited by 65
“LGD mutations in SHANK3 are estimated to contribute to ~1% of all ASD cases 1–3 .”
Mouse Models of Autism: Testing Hypotheses About Molecular Mechanisms
Roullet, F., & Crawley, J. N. (2011) · Current topics in behavioral neurosciences · doi:10.1007/7854_2010_113 · Cited by 68
“…and integrins (Jamain et al. 2003; Laumonnier et al. 2004; Jeffries et al. 2005; Lise and El-Husseini 2006; Autism Genome Project Consortium 2007; Durand et al. 2007; Garber 2007; Moessner et al. 2007; Alarcon et al. 2008; Arking et al. 2008; Jamain et al. 2008; Kim et al. 2008; Lawson-Yuen et…”
BackgroundPerets, N., Oron, O., Herman, S., Elliott, E., & Offen, D. (2020) · Molecular Autism · doi:10.1186/s13229-020-00366-x · Cited by 64
Possible association between the androgen receptor gene and autism spectrum disorder
Henningsson, S., Jönsson, L., Ljunggren, E., Westberg, L., Gillberg, C. I., Råstam, M., Anckarsäter, H. S., Nygren, G., Landén, M., Thuresson, K., et al. (2009) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2008.12.007 · Cited by 73
“…et al., 1989 causes of autism are well known, such as fragile X syndrome, Rett syndrome and tuberous sclerosis, and recently certain rare de novo mutations and copy number variations associated with enhanced risk for autism were identified ( ; ; Durand et al., 2007 Jamain et al., 2003 ).”
Self-citationShank3 Is Part of a Zinc-Sensitive Signaling System That Regulates Excitatory Synaptic Strength
Arons, M. H., Lee, K. C., Thynne, C. J., Kim, S. A., Schob, C., Kindler, S., Montgomery, J. M., & Garner, C. C. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.0116-16.2016 · Cited by 73
Speech and Language: Translating the Genome
Deriziotis, P., & Fisher, S. E. (2017) · Trends in Genetics · doi:10.1016/j.tig.2017.07.002 · Cited by 76
“In another example, a terminal deletion of 22q was found in a girl with autism and severe language impairments, while a partial trisomy of the region was found in her brother, who had Asperger syndrome, with fluent speech and precocious language development [55].”
BackgroundMolecular Dynamics Simulations of Wild Type and Mutants of SAPAP in Complexed with Shank3
Piao, L., Chen, Z., Li, Q., Liu, R., Song, W., Kong, R., & Chang, S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20010224 · Cited by 68
Lorsung, E., Karthikeyan, R., & Cao, R. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.642745 · Cited by 63
Daoud, H., Bonnet‐Brilhault, F., Védrine, S., Demattei, M.-V., Vourc’h, P., Bayou, N., Andres, C. R., Barthélémy, C., Laumonnier, F., & Briault, S. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.05.008 · Cited by 75
Grabrucker, S., Proepper, C., Mangus, K., Eckert, M., Chhabra, R., Schmeißer, M. J., Boeckers, T. M., & Grabrucker, A. M. (2014) · Experimental Neurology · doi:10.1016/j.expneurol.2013.12.015 · Cited by 77
“Durand et al. (2007) identified a mutation in ProSAP2/Shank3 termed “InsG” in a patient with autism.”
BackgroundSelf-citationHayashi, T., Yoshida, T., Ra, M., Taguchi, R., & Mishina, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066254 · Cited by 62
“The observation that mutations in the gene encoding IL1RAPL1 may lead to MR, ASD or both is in line with recent studies noting overlap of genetic loci in susceptibility to these disorders [6–10].”
ResultThe Genetics of Autism Spectrum Disorders – A Guide for Clinicians
Heil, K. M., & Schaaf, C. P. (2012) · Current Psychiatry Reports · doi:10.1007/s11920-012-0334-3 · Cited by 71
The Communication Between the Immune and Nervous Systems: The Role of IL-1β in Synaptopathies
Pozzi, D., Menna, E., Canzi, A., Desiato, G., Mantovani, C., & Matteoli, M. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00111 · Cited by 67
“…Grin2B Receptor function SCZ, ASD, DEP Toro and Deakin, 2005; Kristiansen et al., 2006; Zhang et al., 2014 SHANK-3 Shank3 Postsynaptic function ASD Durand et al., 2007 DISC1 DISC1 Synaptogenesis SCZ Hayashi-Takagi and Sawa, 2010; Hayashi-Takagi et al., 2010 TNIK TNiK Postsynaptic function SCZ…”
BackgroundInfluentialEfficient generation of Knock-in/Knock-out marmoset embryo via CRISPR/Cas9 gene editing
Kumita, W., Sato, K., Suzuki, Y., Kurotaki, Y., Harada, T., Zhou, Y., Kishi, N., Sato, K., Aiba, A., Sakakibara, Y., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-49110-3 · Cited by 67
Mouse Genetic Models of Human Brain Disorders
Leung, C., & Jia, Z. (2016) · Frontiers in Genetics · doi:10.3389/fgene.2016.00040 · Cited by 69
“The Shank proteins are localized to the postsynaptic density and are important in coordinating the assembly of signaling complexes at glutamatergic synapses (Bockers et al., 2001; Durand et al., 2007).”
BackgroundSoler, J., Fañanás, L., Parellada, M., Krebs, M., Rouleau, G. A., & Fatjó‐Vilas, M. (2018) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.170066 · Cited by 71
Eltokhi, A., Rappold, G., & Sprengel, R. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00240 · Cited by 61
Structure of metabotropic glutamate receptor C-terminal domains in contact with interacting proteins
Enz, R. (2012) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2012.00052 · Cited by 68
Psychiatry in a Dish: Stem Cells and Brain Organoids Modeling Autism Spectrum Disorders
Ilieva, M. S., Svenningsen, Å. F., Thorsen, M., & Michel, T. M. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.11.011 · Cited by 68
Gut microbiome: An intermediary to neurotoxicity
Dempsey, J. L., Little, M., & Cui, J. Y. (2019) · NeuroToxicology · doi:10.1016/j.neuro.2019.08.005 · Cited by 66
“Deletion of the gene SHANK3 is associated with dysregulated neurodevelopment and autistic like behaviors (Durand et al., 2007).”
BackgroundZirn, B., Arning, L., Bartels, I., Shoukier, M., Hoffjan, S., Neubauer, B., & Hahn, A. (2010) · Clinical Genetics · doi:10.1111/j.1399-0004.2010.01598.x · Cited by 63
Phelan-McDermid syndrome: a classification system after 30 years of experience
Phelan, K., Boccuto, L., Powell, C. M., Boeckers, T. M., van Ravenswaaij‐Arts, C. M. A., Rogers, R. C., Sala, C., Verpelli, C., Thurm, A. E., Bennett, W. E., et al. (2022) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-022-02180-5 · Cited by 70
Self-citationKumar, R. A., Sudi, J., Babatz, T. D., Brune, C. W., Oswald, D., Yen, M., Nowak, N. J., Cook, E. H., Christian, S. L., & Dobyns, W. B. (2010) · Journal of Medical Genetics · doi:10.1136/jmg.2008.065821 · Cited by 59
Fujita‐Jimbo, E., Yu, Z.-L., Li, H., Yamagata, T., Mori, M., Momoi, T., & Momoi, M. Y. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051155 · Cited by 67
“To date, several genes, including NLGN 3 and 4, CADM1, CNTNAP2, and SHANK3 [1–5], were shown to confer susceptibility to ASD.”
BackgroundAutism: the quest for the genes
Sykes, N. H., & Lamb, J. A. (2007) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399407000452 · Cited by 58
Zinc Stabilizes Shank3 at the Postsynaptic Density of Hippocampal Synapses
Tao-Cheng, J.-H., Toy, D., Winters, C. A., Reese, T. S., & Dosemeci, A. (2016) · PLOS ONE · doi:10.1371/journal.pone.0153979 · Cited by 58
“Shanks are involved in aspects of synaptic development and function [2], and Shank3 was the first to be implicated in autism spectrum disorders [3].”
BackgroundMajor motor and gait deficits with sexual dimorphism in a Shank3 mutant mouse model
Matas, E., Maïsterrena, A., Thabault, M., Balado, É., Francheteau, M., Balbous, A., Galvan, L., & Jaber, M. (2021) · Molecular Autism · doi:10.1186/s13229-020-00412-8 · Cited by 62
“3 microdeletion syndrome, also known as Phelan-McDermid Syndrome [13].”
BackgroundIvashko‐Pachima, Y., Ganaiem, M., Ben-Horin-Hazak, I., Lobyntseva, A., Bellaiche, N., Fischer, I., Levy, G., Sragovich, S., Karmon, G., Giladi, E., et al. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01603-w · Cited by 62
“The InsG3680 mouse carries a patient-derived frameshift-STOP Shank3 mutation [28, 34] and exhibits major deficits in cortico-striatal synaptic transmission, with aberrant electrical activity, and autistic-like behavior [28].”
BackgroundDelahaye‐Duriez, A., Toutain, A., Aboura, A., Dupont, C., Tabet, A., Benzacken, B., Élion, J., Verloès, A., Pipiras, E., & Drunat, S. (2009) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2009.05.004 · Cited by 62
Verhoeven, W. M. A., Egger, J., Willemsen, Leijer, D., & Kleefstra (2012) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s30506 · Cited by 57
FMR1 and Autism, an Intriguing Connection Revisited
Fyke, W., & Velinov, M. (2021) · Genes · doi:10.3390/genes12081218 · Cited by 56
Parvalbumin and parvalbumin chandelier interneurons in autism and other psychiatric disorders
Juárez, P., & Martínez‐Cerdeño, V. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.913550 · Cited by 68
de Bartolomeis, A., & Tomasetti, C. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8293-6 · Cited by 65
Lin, C.-W., & Hsueh, Y. (2013) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2013.12.002 · Cited by 59
Rapin, I., & Tuchman, R. F. (2008) · Current Opinion in Neurology · doi:10.1097/wco.0b013e3282f49579 · Cited by 54
Disruption of the epigenetic code: An emerging mechanism in mental retardation
van Bokhoven, H., & Kramer, J. M. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.03.010 · Cited by 55
Chana, G., Laskaris, L., Pantelis, C., Gillett, P., Testa, R., Zantomio, D., Burrows, E. L., Hannan, A. J., Everall, I., & Skafidas, E. S. (2015) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2015.05.009 · Cited by 69
Variability in Phelan-McDermid Syndrome in a Cohort of 210 Individuals
Nevado, J., García‐Miñáur, S., Palomares‐Bralo, M., Vallespín, E., Guillén‐Navarro, E., Rosell, J., Fenellós, C. B., Mori, M. Á., Milà, M., Campo, M. D., et al. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.652454 · Cited by 62
Scaffold proteins as dynamic integrators of biological processes
DiRusso, C. J., Dashtiahangar, M., & Gilmore, T. D. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.102628 · Cited by 67
“SHANK3 is a neuronal-specific scaffold found at the postsynaptic density (PSD) of excitatory synapses (47).”
BackgroundWei, H., Dobkin, C., Sheikh, A. M., Malik, M., Brown, W. T., & Li, X. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036981 · Cited by 55
“detected in some autistic subjects [56,57].”
Autism spectrum disorder and schizophrenia: boundaries and uncertainties
Pina‐Camacho, L., Parellada, M., & Kyriakopoulos, M. (2016) · BJPsych Advances · doi:10.1192/apt.bp.115.014720 · Cited by 66
“There is also some evidence that de novo mutations in the same genes (e.g. SHANK3 ) could account for a number of cases of schizophrenia (Gauthier 2010) and ASD (Durand 2007).”
Atypical developmental patterns of brain chemistry in children with Autism Spectrum Disorder
Corrigan, N. M., Shaw, D. W. W., Estes, A. M., Richards, T. L., Munson, J., Friedman, S. D., Dawson, G., Artru, A. A., & Dager, S. R. (2013) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.1388 · Cited by 54
Metadata
- Authors
- Durand, C. M., Betancur, C., Boeckers, T. M., Bockmann, J., Chaste, P., Fauchereau, F., Nygren, G., Rastam, M., Gillberg, I. C., Anckarsäter, H., Sponheim, E., Goubran-Botros, H., Delorme, R., Chabane, N., Mouren-Simeoni, M.-C., de Mas, P., Bieth, E., Rogé, B., Héron, D., Burglen, L., Gillberg, C., Leboyer, M., & Bourgeron, T.
- Affiliations
- Institut Pasteur (FR)
- Inserm (FR)
- Universität Ulm (DE)
- University of Gothenburg (SE)
- University of Oslo (NO)
- Assistance Publique – Hôpitaux de Paris (FR)
- Université Toulouse - Jean Jaurès (FR)
- Pitié-Salpêtrière Hospital (FR)
- St George's Hospital (GB)
- Corresponding author
- Bourgeron, Thomas
- ORCID
- Venue
- Nature Genetics
- Published
- 2006-12-17
- Volume
- 39
- Issue
- 1
- Pages
- 25-27
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- PMC
- PMC2082049
- OpenAlex
- W1983194657
- Cited by
- 1,602
- References
- 16
- Citations by year
- 2026: 48 · 2025: 40 · 2024: 75 · 2023: 71 · 2022: 78 · 2021: 91 · 2020: 85 · 2019: 68 · 2018: 81 · 2017: 99 · 2016: 79 · 2015: 96 · 2014: 78 · 2013: 97 · 2012: 114
- FWCI
- 33.51
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- HAL (submittedVersion, other-oa)
- Lund University Publications (Lund University) (submittedVersion)
- Funders
- George Washington University
- Georgetown University
- Children's National Hospital
- European Commission
- Deutsche Forschungsgemeinschaft (SFB 497)
- Institut National de la Santé et de la Recherche Médicale
- Fondation pour la Recherche Médicale
- Fondation de France
- Universitetet i Oslo
- Assistance publique-Hôpitaux de Paris
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- SHANK3, autism spectrum disorder, neuroligins, dendritic spines, synaptic scaffolding, chromosome 22q13, gene dosage sensitivity, language disorders, social communication disorder, Asperger syndrome
- MeSH terms
- Autistic Disorder, Base Sequence, Carrier Proteins, DNA Mutational Analysis, Female, Genetic Testing, Humans, Male, Molecular Sequence Data, Mutation, Nerve Tissue Proteins, Pedigree, In Situ Hybridization, Fluorescence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.